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Mitochondria play an essential role in cell metabolism as well as apoptotic signaling. 
Chronic endurance exercise has been shown to increase mitochondrial content in skeletal 
muscle. Interestingly, endurance exercise has also been associated with decreased skeletal 
muscle apoptosis; however, the direct effect of increased skeletal muscle mitochondrial content 
on apoptotic signaling has not been examined. The purpose of this study was to induce 
mitochondrial biogenesis in L6 myoblasts and examine the susceptibility of these cells to 
stress- induced apoptosis.  Mitochondrial biogenesis was accomplished using 5-
Aminoimidazole-4-carboxamide-ribonucleoside (AICAR) and S-nitroso-N-acetylpenicillamine 
(SNAP), which activate AMPK and donate nitric oxide, respectively. Successful induction of 
mitochondrial biogenesis was determined by western blot analysis for mitochondrial specific 
markers. Following SNAP and AICAR treatment, the average increase in the mitochondrial 
markers was 24% and 38%, respectively. Subsequent exposure of cells to several apoptosis-
inducing agents increased apoptosis. Interestingly, SNAP- and AICAR- treated cells had a 
lower percentage of apoptotic cells as determined by AnnexinV-FITC/PI fluorescent staining, 
cell cycle analysis, and cell counting/size analysis. In addition, it was shown that SNAP- and 
AICAR-treated cells had reduced caspase-3 activity following exposure to apoptotic stimuli.  
Furthermore, treatment with SNAP and AICAR resulted in increased protein content of the 
antioxidants MnSOD and catalase. Interestingly, mitochondrial ROS production was not 
significantly altered between groups with total cellular ROS production being increased in the 
SNAP- and AICAR-treated groups. In summary, this work demonstrates that increasing 
mitochondrial content in L6 myoblasts provides protection against stress-induced apoptosis. 
The mechanism for this protective effect remains to be determined; however, it may be 
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mediated by a combination of increased antioxidant capacity and improved mitochondrial 
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The purpose of this literature review is to examine apoptotic signaling and 
mitochondrial biogenesis. An in-depth description of the apoptotic signaling pathways and 
their regulation will be given. Furthermore, a review of the current literature in regards to 
apoptotic signaling and physical activity in skeletal muscle will be described. The processes 
regulating mitochondrial biogenesis both in vivo and in vitro will also be reviewed. Upon 
reading this literature review it will become evident that the relationship between endurance 
training and apoptosis has been thoroughly examined in rodent models; however, the specific 
effect of mitochondrial biogenesis on apoptotic signaling has not been established. The review 
will conclude with some possible linkages between mitochondrial biogenesis and apoptotic 
signaling indicated in the literature. 
 
Apoptosis in Health and Disease 
Apoptosis is a fundamental process for normal development as well as for 
physiological cell turnover. Physiologically, the role of apoptosis is vast. For example, 
apoptosis is required for the formation of body cavities [1], is involved in homeostatic 
regulation of cell number [1,2], embryogenesis, the morphogenesis of fingers and toes [1], and 
in cellular injury [1]. In addition to these important physiological roles, dysregulation of this 
tightly regulated process can have severe consequences. It is well established that a balance 
between an appropriate amount of apoptosis and too much apoptosis is important in the 
pathogenesis of disease as an upregulation can lead to tissue damage and atrophy whereas 
down-regulation can lead to cellular overgrowth. Hence, apoptosis is implicated in 
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pathogenesis of many disease states including acquired immunodeficiency syndrome (AIDS), 
where the HIV virus causes death of T-helper cells which are required for proper immune 
function [3]. Excess apoptotic cell death is also implicated in other autoimmune diseases such 
as Hashimoto‘s thyroiditis [4]as well as cardiovascular diseases[5] and in neuronal diseases 
like Alzheimer‘s and Parkinson‘s[6]. On the other hand, an inhibition of apoptosis in a number 
of tissues is the basis of cancerous tumor formation [1,2,7]. Due to its involvement in 
numerous disease states, a great deal of research is examining apoptotic regulators as potential 
therapeutic treatments.    
 
Regulation of Apoptosis 
Apoptosis is a tightly regulated process controlled by the activation of a pre-existing 
program within the genome and can be distinguished from other types of cell death such as 
necrosis. Necrosis tends to occur in response to injury by toxins, physical trauma, or ischemia 
[1,8]. This type of cell death is characterized by cellular swelling, disruption of membrane 
integrity, cellular leakage, and lysis of nuclear chromatin [1,2,8]. Necrosis also often involves 
large groups of cells and since large volumes of cellular contents leak into the extracellular 
space, it often elicits an intense inflammatory response [8]. Apoptosis, on the other hand, is a 
tightly controlled, energy dependent mechanism characterized by cell shrinkage, nuclear 
condensation, DNA fragmentation, and membrane blebbing that eventually lead to 
phagocytosis of the dying cell with little or no inflammatory response [1,8,9]. Although 
apoptosis and necrosis can be considered separate entities, certain circumstances involving 
cellular stress imposed by toxins, physical trauma, or ischemia, may cause cell death via 
necrosis as well as apoptosis [1]. The ultimate death pathway a cell follows (apoptotic or 
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necrotic) is often determined by the type, intensity, and duration of death stimuli as well as the 
energy capacity remaining within the cell. In addition, in vitro models lack the phagocytes that 
are normally required for clearance of apoptotic bodies. When clearance of the apoptotic cell 
does not occur, the cell moves through the apoptotic process until a transition is made to 
necrosis [10]. This transition to necrosis is known as secondary necrosis [10].  These cells that 
once showed characteristics of apoptosis begin to show necrotic characteristics such as ATP 
depletion, swelling, membrane rupture, and release of cellular contents [10]. 
Apoptosis can be triggered by many different stimuli but execution occurs through two 
main pathways; the extrinsic and intrinsic pathways. Both pathways have overlapping 
characteristics in the sense that there is an initiation phase (receipt of death inducing signals) 
and an execution phase (nuclear and cellular breakdown). The execution phase is initiated by 
activation of specific proteolytic enzymes known as caspases [11] (cysteine-aspartic proteases).  
Caspases are produced and stored within the cytosol as inactive proenzymes and as 
procaspases [11]. In order to perform their proteolytic function, they must first be cleaved at 
specific aspartic residues into their active form. Caspases involved in the apoptotic pathways 
can be divided into two groups, initiator caspases (caspases-8, -9, -10) and effector caspases 
(caspases-3, -6, -7) [11,12]. Upon activation of the initiator caspases, they begin breaking 
down intracellular proteins important for regular cell function, as well as cleaving and thereby 
activating effector caspases [11,12,13].  The effector caspases then continue to break down 
important cellular and nuclear proteins such as the nuclear enzyme poly ADP- ribose 
polymerase (PARP) (an important DNA repair enzyme) as well as cleaving more procaspases 
[11,12]. This caspase signaling cascade ultimately results in massive cellular degradation and 
cell death [11].      
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In the intrinsic apoptotic pathway, death can be triggered in response to a variety of 
signals such as UV irradiation, oxidative stress, growth factor withdrawal, or cytotoxic drugs 
[1,2,14].  These stress signals result in the activation of Bax, a cytosolic protein which 
translocates to the mitochondria. At the mitochondria, Bax participates in the formation of 
pores in the outer membrane which ultimately allows for the release of cytochrome c into the 
cytosol [14,15,16,17]. Upon release into the cytosol, cytochrome c binds to the Apoptotic 
Protease Activating Factor-1 (Apaf-1) along with procaspase-9 and dATP forming the 
apoptosome [1,11]. Formation of the apoptosome activates self cleavage of procaspase-9 to 
caspase-9. Subsequently, caspase-9 activates downstream effector caspases (eg. caspase -3, -6, 
-7), ultimately leading to breakdown of cellular substrates and eventual cell death [1,11,14] 
(see figure 1).  
In addition to caspase-mediated cell death, there are also caspase-independent 
mechanisms that can mediate apoptotic cell death through the intrinsic pathway. Upon 
receiving a pro-apoptotic signal, the mitochondria can release apoptosis-inducing factor (AIF) 
and endonuclease G (EndoG), both of which translocate to the nucleus and induce DNA 




Figure 1. Intrinsic (mitochondrial) pathway of apoptosis. Intrinsic cellular stresses result in 
Bax activation and translocation to the mitochondria membrane and subsequent pore 
formation. Mitochondria release cytochrome c which leads to the formation of the apoptosome 
and subsequent activation of the caspase cascade ultimately leading to cell death. Mitochondria 
can also release caspase independent factors AIF and Endo G, which translocate to the nucleus 
and initiate cell death by cleavage of nuclear factors.   
 
In the extrinsic pathway, the decision for cell survival or death is determined though 
signals received extracellularly. The extracellular signals are often a combination of cessation 
of anti-apoptotic cell survival signals and receipt of positive apoptotic signals binding to what 
are commonly known as the ‗death receptors‘ [1,18]. The two main death receptors are known 
as the tumor necrosis factor receptor-1 (TNFR1), and the Fas (CD-95) receptor [1,2,19]. Each 
receptor has an amino acid sequence that projects into the cell which is known as the death 
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domain (DD) [1,2]. Apoptotic cell death is initiated by the binding of tumor necrosis factor-α 
(TNF-α), or Fas ligand (FasL) to their respective receptors. Upon binding of ligands to 
receptors, intracellular signals recruit the adaptor proteins known as TNFR-associated death 
domain protein (TRADD) and Fas-associated death domain protein (FADD) which bind to the 
death domain to form the death inducing signaling complex (DISC) [1,2,7,19]. Pro-caspase-8 
then binds to the death effector domain (DED) on the DISC resulting in its cleavage to the 
active form caspase-8 which sequentially activates the effector caspases (eg. caspase-3, -6, -7) 
[1,2,12]. Activation of effector caspases then results in the breakdown of cellular and nuclear 
substrates much like the intrinsic pathway [1,19,20,21]. Activation of caspase-8 can also lead 
to cleavage and activation of BID, a cytosolic protein which translocates to the mitochondria 
and causes cytochrome c release, ultimately linking the extrinsic (death receptor) and intrinsic 




Figure 2. Extrinsic (Death Receptor) pathway of apoptosis. Biding of the appropriate ligand 
to the death receptor on the cell membrane results in formation of the death inducing signaling 
complex (DISC) consisting of pro-caspase 8 and bound with FADD or TRADD to the death 
domain of the death receptor.  Formation of the DISC results in activation of caspase-8 with 
can then cleave caspase-3 which ultimately leads to cleavage of more apoptotic substrates and 
cell death. Caspase-8 can also cleave and activate Bid which then translocates to the 
mitochondrial membrane causing pore formation and activation of the intrinsic pathway of 
apoptosis.   
 
Another important apoptotic pathway is the calcium-dependent calpain-mediated 
pathway. Calcium plays a large role in intracellular signaling and a number of effects on 
numerous processes. For example, in skeletal muscle cytosolic calcium is involved in 
metabolism, muscle contraction, transcription activation, and proliferation [21]. Given that 
calcium signaling plays such a vital role in normal cellular function, it is not surprising that it is 
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also a player in apoptotic signaling. Calcium‘s role in apoptosis can vary depending on tissue 
type but its execution pathways are consistent between tissues [22]. In this pathway, calcium-
dependent proteases known as calpains are activated in response to imbalances in calcium 
regulation. Calpains are structurally similar to caspases and function in a very similar fashion, 
cleaving many of the same apoptotic proteins as caspases [22,23,24]. Calpains can cleave and 
activate the Bcl-2 family proteins Bid and Bax which can then translocate to the mitochondria 
and induce pore formation at the membrane [22].  Additionally, calpains can activate caspase-
12, an effector caspase which can act on mitochondria and induce them to release pro-apoptotic 
factors [22,23,25]. Calpains can also cleave a number of proteins required for DNA repair and 
cell cycle regulation, thereby disrupting normal cell function and promoting cell death [22].  
 
Apoptosis Regulatory Proteins 
There are many proteins that effect the regulation of apoptosis which can be either pro- 
or anti-apoptotic and can act at different points within the apoptotic pathway. For example, in 
the extrinsic pathway, the protein TRAF2 (TNF receptor-associated factor 2) interacts with the 
TNFR-1 and TRADD to prevent binding and subsequent caspase-8 activation [1,19,20]. 
TRAF2, along with the binding of other inhibitors of apoptosis proteins (IAPs), activates NF-
κB, which mediates up-regulation of anti-apoptotic genes such as FLIPs [19,20].  FLIPs 
(FLICE inhibitory proteins) can bind to the death domain of Fas and TNFR1 and prevent DISC 
formation and subsequent activation of caspase-8, thereby inhibiting apoptosis [1,26]. 
In the intrinsic pathway, the Bcl-2 family of proteins comprises a large portion of these 
apoptotic regulatory proteins. Pro-survival members of the Bcl-2 family include Bcl-2, Bcl-xL, 
Bcl-w, Mcl-1, Bim, and EGL- 1[15,16]. These proteins tend to be found in membranes such as 
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those of the mitochondria, endoplasmic reticulum, and the nucleus [16]. One of the main 
functions of these proteins is to inhibit mitochondrial pore formation and release of cytochrome 
c and other pro-apoptotic proteins from the mitochondria [15,16,17]. Pro-apoptotic members of 
the Bcl-2 family can be subdivided into two subfamilies: the Bax family, which includes Bax, 
Bak, Bok, Bcl-rambo, and Bfk, and the BH-3 family, which includes Bid, Bad, Bik, Bim, Bmf, 
Noxa, Puma, and Hrk [15,16].  These proteins are found mainly within cytosolic portions of 
the cell but upon receiving the appropriate death stimuli, they migrate to the mitochondria to 
induce pore formation [16]. Hence, the balance of the two major pro-apoptotic and anti-
apoptotic Bcl-2 family proteins (the Bax:Bcl-2 ratio) is a useful indictor to determine a cells 
fate or susceptibility to apoptotic death [16].    
Another protein that has a critical role in apoptotic signaling is apoptosis repressor with 
caspase recruitment domain (ARC). ARC is a unique protein in that it has only been shown to 
be expressed in heart, skeletal muscle, vascular muscle, and the brain [5,27,28]. It is also 
unique in that unlike other anti-apoptotic proteins it has the ability to inhibit apoptosis by 
interacting in both the intrinsic and extrinsic death pathways. In the extrinsic pathway, ARC 
successfully inhibits apoptosis by binding to the death domains of both the Fas receptor and 
FADD thereby inhibiting caspase-8 activation [27,28]. In the intrinsic pathway, ARC can 
prevent apoptosis by binding to the C-terminus of Bax, which inhibits the conformational 
change that results in Bax activation and subsequent translocation to the mitochondrial 
membrane [27]. Cellular ARC content has also been shown to be altered in disease states such 
as cardiovascular diseases [5,29] and cancer [30], which suggest it may be a key player in 
regulating apoptosis in disease states. ARC has also been shown to be rapidly degraded upon 
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apoptotic stimuli such as reactive oxygen species [31], therefore observations of ARC levels 
may be important when studying muscle apoptosis. 
 
Apoptotic Signaling in Skeletal Muscle 
Apoptosis is a biological process conserved across many tissues and species; however, 
the mechanisms by which different types of tissue undergo apoptosis can vary. Skeletal muscle 
is particularly unique from most other tissues due to its multi-nucleated morphology. In most 
tissues, initiation of apoptosis results in removal of an entire cell, but skeletal muscle can 
undergo what has been termed myonuclear apoptosis, a process where only individual nuclei 
and their associated cytoplasmic portions are lost [32,33,34]. Although the fate of the cell 
differs, the traditional characteristics of apoptosis, such as elevated Bax/Bcl-2 ratio, elevated 
AIF release, elevated caspase-3, -8, -9, cytochrome-c release, Smac/Diablo release, nuclear 
condensation and degradation, all occur in skeletal muscle just as it would in many other 
tissues [32,35].  
Upon apoptotic removal of specific nuclei, specialized progenitor cells located between 
the sarcolemma and the basal membrane known as satellite cells become activated [36,37]. 
Once activated, satellite cells migrate to the site of damage or nuclear removal, and can fuse to 
fiber, forming new myonuclei and cytoplasmic regions, thereby repairing the cell [34,36]. The 
satellite cells; however, do not have infinite availability and the satellite cell ‗pool‘ can become 
depleted over time [38,39]. In degenerative skeletal muscle states, including motor nerve 
denervation, aging, atrophy due to immobilization, and Duchenne muscular dystrophy, satellite 
cell numbers and subsequent proliferative and repair potential significantly decreases [40]. 
Hence, the limited capacity for muscle regeneration plays a large role in many disease states in 
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which increased susceptibility to apoptosis in skeletal muscle is implicated and plays a large 
role in the atrophy of muscle in disuse and aging [38,39].     
 Mitochondria play a very important role in cell metabolism, not only for energy 
generation, but also for being a major site for production of reactive oxygen species (ROS) and 
apoptotic signaling [41]. In skeletal muscle, there are a number of fiber types characterized by 
their myosin heavy chain expression and their oxidative capacity. Fibers that are more 
oxidative have greater mitochondrial content [42]. Most skeletal muscle contains a mixed 
population of fiber type; however some muscles have varying degrees of expression of certain 
fiber types. For example, the slow twitch soleus muscle of rats is highly oxidative and is 
composed mostly of type I fibers whereas extensor digitorum longus (EDL) muscle of rat is 
glycolytic and expresses mainly type IIb and IIx fibers[43]. Studies have found that content of 
apoptotic proteins can vary between muscle groups in response to exercise [44,45,46,47], 
suggesting that individual fiber types may differ in their susceptibility to apoptosis. Due to the 
fact that mitochondria play such a vital role in apoptotic signaling, that mitochondrial content 
can vary between muscle groups and fiber types, and that mitochondrial content can be altered 
in skeletal muscle in response to various stimuli, mitochondria have become a main area of 
focus in the study of apoptosis in skeletal muscle. 
  
Mitochondrial Biogenesis - Introduction and Basic Mechanisms 
Given the importance of mitochondria in apoptotic signaling, it is understandable that 
altering mitochondrial content could have a drastic effect on apoptotic signaling within skeletal 
muscle. Mitochondrial biogenesis refers to the growth of existing mitochondria or to the 
growth and development of new functional mitochondria [48]. Mitochondrial biogenesis is a 
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complex process that can be activated through many mechanisms. Peroxisome proliferator-
activated receptor (PPAR)-γ coactivator-1α (PGC-1α) is a transcriptional coactivator, meaning 
that it increases the rate of transcription of certain genes by interacting with transcription 
factors but does not itself bind to DNA [49]. PGC-1α has been shown to be one of the main 
regulators of mitochondrial biogenesis and does this by increasing many nuclear transcription 
factors involved in the expression of both nuclear and mitochondrial encoded genes required 
for mitochondrial proliferation [50,51,52]. PGC-1α‘s main target in inducing mitochondrial 
biogenesis is nuclear respiratory factor-1 (NRF-1) and -2 (NRF-2)[52]. NRF-1 and -2 proteins 
form homodimers and function as transcription factors that are responsible for activating genes 
that encode for mitochondrial transcription factor A (mtTFA) (also known as Tfam) as well as 
other mitochondrial oxidative enzyme proteins such as cytochrome c oxidase and delta-
aminolevulinate synthase (ALAS )[53].   mtTFA then activates the mitochondrial genes 
involved in mitochondrial DNA transcription and replication such as mitochondrial DNA 
polymerase [49].  
The importance of PGC-1α in muscle mitochondrial biogenesis has been clearly 
demonstrated by gene overexpression models in vitro. In C2C12 muscle cells, over-expression 
of PGC-1α led to significantly increased gene expression of cytochrome c, COXIV, COXII, 
elevated mitochondrial DNA copy number, and increased mitochondrial volume [54]. 
Similarly, Bianchi et al. [55] found that L6 muscle cells transfected with PGC-1α had 
significantly increased NRF-1 expression as well as significantly increased mitochondrial 
volume. In addition, transgenic mice over-expressing PGC-1α show similar increased RNA 
levels of COXII and COXIV, as well as increased protein expression of cytochrome c [56]. 
Interestingly, complete knockout of the PGC-1α gene in rats resulted in significant decreases in 
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total mitochondrial content in skeletal muscle [52]. In addition, complete knockout of PGC-1α 
in mice has been shown to result in a high fetal mortality rate [57], highlighting the importance 
of PGC-1α‘s role in survival.  
 
Activity and Mitochondrial Biogenesis 
Exercise has been demonstrated to increase mitochondrial volume whereas physical 
inactivity has been shown to have the opposite effect [50,51].  Terada et al. [58] have 
demonstrated that a single bout of prolonged exercise in rats can lead to a significant increase 
in PGC-1α mRNA expression and can also increase NRF-1 and NRF-2 binding activity [59] 
signifying that exercise activates the mitochondrial biogenesis signaling pathway. In addition, 
five daily bouts of endurance exercise in rats results in significant increases in ALAS, citrate 
synthase, cytochrome c oxidase I (COXI), and cytochrome c in comparison to control rats. 
Similar results have also been found in human studies. For example, 24 weeks of endurance 
exercise led to significantly higher levels of mitochondria in quadriceps muscle of young 
females compared to that of controls [60]. 
In contrast, prolonged physical inactivity is has been shown to be related to decreased 
mitochondrial content. In a study using hindlimb unweighting as a model of inactivity in rats, 
Desplanches et al. [61] found that the absolute volume of subsarcolemmal and inter-
myofibrillar mitochondria significantly decreased by 65% and 35% respectively compared to 
control animals. Similarly, following 21 days of skeletal muscle denervation in rats, it was 
found that PGC-1α and cytochrome c protein levels were significantly reduced [62]. 
Additionally, Timmons et al. [63] found that following unilateral unloading of the lower limb 
in humans, mRNA expression of PGC-1α, citrate synthase, COXIV, and Tfam were all 
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significantly reduced compared to the control limb. Taken together, these data suggest a strong 
link between physical activity levels and mitochondrial content in skeletal muscle.   
 
Factors Regulating Mitochondrial Biogenesis 
 Calcium  
The mechanisms by which physical activity may modulate mitochondrial content 
within muscle are vast given that contractile activity can lead to a number of biochemical and 
signaling events. As such, several pathways in which the initial cellular perturbations 
associated with muscle activity leading mitochondrial biogenesis have been described. Calcium 
release from the sarcoplasmic reticulum is an important signal that initiates force production 
but it is also an important second messenger within the cell that has been implicated in the 
activation of transcription factors regulating mitochondrial biogenesis [64]. Increases in 
calcium lead to the activation of calcium-calmodulin dependent kinases (CaMK), protein 
kinase C (PKC), calcineurin, and p38 mitogen-activated protein kinase (p38 MAPK) [50,51].  
All together, these factors can initiate mitochondrial biogenesis through the activation of PGC-
1α [52,65,66]. For example, overexpression of CaMKIV in mouse muscle was demonstrated to 
significantly increase PGC-1α RNA levels, cytochrome c protein expression, and 
subsarcolemmal mitochondrial content [67] . 
 In addition, several cell culture experiments using L6 myoblasts or differentiated L6 
myotubes have shown that calcium administration results in mitochondrial biogenesis. For 
example, Ojuka et al. [68,69,70] demonstrated that intermittent treatments with caffeine or the 
calcium ionophore ionomycin, both of which stimulates calcium release from the sarcoplasmic 
reticulum, resulted in significant increases in mitochondrial enzymes. They found significant 
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increases in the protein content of ALAS, COX1, COXIV, cytochrome c, and citrate synthase 
[69,70,71,72]. In addition, caffeine administration to L6 myotubes which stimulates 
intracellular calcium release from the sarcoplasmic reticulum has been shown to up-regulate a 
number of the transcription factors/co-factors including PGC-1, NRF-1, and NRF-2 [70,71]. 
Interestingly, administration of a CaMK inhibitor (KN93) along with caffeine administration 
completely blocks the calcium induced increases in the mitochondrial marker proteins, 
suggesting calcium works through a CaMK mediated pathway to induce mitochondrial 
biogenesis [70]. Ultimately this research provides strong evidence for an important role of 
calcium in the process of mitochondrial biogenesis. 
 
 AMPK 
AMPK has been established as an important signaling molecule within the cell and acts 
as a major sensor for AMP level in cells [72]. This enzyme is activated by cellular stresses that 
result in ATP depletion. Stimuli of AMPK are generally either processes that inhibit ATP 
production (e.g. metabolites, hypoxia, or glucose deprivation) or increase ATP consumption 
(e.g. muscle contraction) [73]. AMPK is also activated by the adipokines leptin and 
adiponectin, important regulators of whole-body energy metabolism [73]. Additionally, AMPK 
plays a large role in the signaling pathway regulating mitochondrial biogenesis. Exercise and 
cell culture studies suggest that AMPK works through PGC-1α to induce mitochondrial 
biogenesis [72]. Terada et al. [58] showed that 6 hours of low intensity swimming resulted in 
increased AMPK activation and PGC-1α mRNA expression. Electrical stimulation designed to 
mimic endurance exercise also activated AMPK and increased PGC-1α protein expression 
[74]. Similarly, this effect can also be observed in vivo following exposure of L6 myotubes to 
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the AMPK activating drug, 5-Aminoimidazole-4-car- boxamide-β-D-ribofuranoside (AICAR), 
as shown by elevated AMPK and CaMK phosphorylation [69].  In addition, it was shown that 
exposure of L6 myoblasts to AICAR, resulted in significant increases in ALAS, cytochrome c, 
PGC-1α, COXI and COXIV protein expression compared with control cells [69,70,71]. 
Interestingly, administering the nitric oxide synthase (NOS) inhibitor, L-NAME, results in 
attenuation of the AICAR-induced increases in mitochondrial biogenesis markers, signifying 
that there is also a role for nitric oxide in mitochondrial biogenesis [71]. 
 
Nitric Oxide 
Nitric oxide (NO) is a simple diatomic molecule with complex pleiotropic implications 
in cell signaling [75]. NO has an unpaired electron which allows it to react rapidly with other 
molecules and at the same time, can diffuse easily through plasma membranes to reach target 
cells due its lipophillic nature [76]. NO is produced endogenously by nitric oxide synthase 
(NOS) which catalyzes the oxidation of L-arginine to L-citruline[76,77]. In skeletal muscle, 
NO has also been shown to modulate mitochondrial biogenesis in response to exercise and in 
calorie restriction. For example, Civitarese et al. [77] showed that calorie restriction of 25% or 
calorie restriction of 15% with increased daily exercise by 15% results in significant increases 
in mitochondrial content within skeletal muscle. It was also shown that caloric restriction led to 
significantly increased activity of NOS, indicating a role for NO in mitochondrial biogenesis 
[48,77,78]. Interestingly, eNOS knockout animals have been shown to demonstrate a reduced 
exercise capacity [79] and have a reduced mitochondrial content within skeletal muscle 
[77,80,81]. Cell culture studies in human, rat, and mouse myoblasts and myotubes have shown 
that intermittent administration of NO donors results in increased PGC-1α and NRF-1 mRNA 
17 
 
content and protein expression, as well as increased expression of other mitochondrial markers 
such as cytochrome C, COXI, COXIV, and mtTFA [71,77,80]. Furthermore, it has been shown 
that NO works through cGMP mediated pathway, as administration of the cGMP analog 8 Br-
cGMP results in similar increases in PGC-1α, NRF-1, COXIV and cytochrome c expression 
[80]. In addition, administration of the cGMP inhibitor ODQ abolishes the effects of the NO 
donor and 8- Br-cGMP on mitochondrial content in cultured myoblasts [80]. Mitochondrial 
biogenesis within skeletal muscle is a complicated process that involves the coordinated 
signaling of many different molecules. A simplified summary of the process is shown figure 3. 
 
Figure 3. Schematic of mitochondrial biogenesis pathways in skeletal muscle. Skeletal 
muscle contraction leads to increased in intracellular calcium, increase NOS activity and 
increased AMPK activity which can lead to increase PGC-1α content. Increased PGC-1α leads 




Activity and Apoptosis 
Acute Exercise 
Exercise has well been established as a physiological stimulus that alters a number of 
biochemical and cellular processes. Recently it has been demonstrated that exercise can alter 
apoptotic signaling in a number of tissues including skeletal muscle. For example, acute 
strenuous exercise has been shown to alter several apoptotic proteins and signaling events. In 
healthy mice and rats, single bouts of spontaneous wheel running has shown altered Bcl-2 
family protein expression, increases in myonuclei apoptosis, and increases in caspase activity 
[44,82,83]. Similarly, a single bout of treadmill running in healthy rats has been shown to 
increase reactive oxygen species (ROS) generation which may mediate the corresponding 
increases seen in muscle caspase activity and appearance of apoptotic nuclei [84,85].  In 
addition, it has been demonstrated that acute exercise in healthy humans alters skeletal muscle 
Bcl-2 family gene expression [87,88]  as well as caspase-3 mRNA levels [87], protein content, 
and proteolytic activity [86,87,88]. 
 
Regular Exercise 
Regular treadmill exercise or endurance training has also been shown to positively 
influence apoptosis-specific protein and mRNA expression and decreases DNA fragmentation 
in skeletal muscle [46,89,90].  For example, Siu and colleagues [89] demonstrated that in 
response to endurance training, mRNA levels and protein content of XIAP increased 
significantly compared to controls. Additionally, it was shown that ARC and FLIP protein 
content are significantly elevated in skeletal muscle of exercised animals compared to controls 
[89].  It has also been demonstrated that endurance trained rats express increased levels of the 
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anti-apoptotic proteins Bcl-2 [45,90], HSP70 [90,91], and MnSOD [90]  while expressing 
reduced levels of the pro-apoptotic proteins Bax [45] and cleaved caspase-3 [45]. In addition, 
Bax mRNA content and Apaf-1 protein content in the skeletal muscle of the trained animals is 
significantly lower than that of controls [90]. Collectively, these data suggest that endurance 
training has a significant anti-apoptotic effect on skeletal muscle.  
 
Inactivity and Aging 
Interestingly, inactivity and aging, have been shown to be associated with increased 
apoptotic signaling [45,92].  For example, Leeuwenburgh et al. [93] showed that there was a 
significant increase in the level of apoptosis, by TdT- mediated dUTP nick end labeling 
(TUNEL) and DNA fragmentation, in aged rats compared to young controls. They also found 
that in response to hindlimb unweighting, there were significant increases in apoptosis in both 
young in old rats [93]. It has also been demonstrated that the anti-apoptotic proteins XIAP and 
ARC both significantly decrease in aging [94] while endoG localization to the nucleus has also 
been shown to be increased in hindlimb unweighting [93] as well as aging [93,95].     
 
Links Between Mitochondrial Biogenesis and Apoptosis 
Introduction 
Given the important role of mitochondria in cell function as well as apoptosis, it is not 
unexpected to hypothesize that changes in mitochondrial content could have a strong affect on 
apoptotic signaling. Currently literature suggests exercise training can increase mitochondrial 
biogenesis [52,59,61] and decreased apoptosis [45,89,90] whereas inactivity leads to decreased 
mitochondrial content [61,62,63] and is associated with increased apoptotic signaling [93,95]. 
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Similarly, caloric restriction can lead to increased mitochondrial biogenesis [48,77,78] and 
decreased apoptosis [94] whereas aging is associated with decreased mitochondrial content 
[96] and increased levels of apoptosis [45,92]. Collectively this suggests that there may be a 
relationship between mitochondrial content and muscle apoptosis. Currently, this relationship 
has not been systematically been studied, however, potential mechanisms for this relationship 
can be deduced from the literature. A review of the current literature suggests that altering 
mitochondrial content may function to mediate apoptotic signaling by two main pathways; by 
reducing ROS production and by maintaining calcium homeostasis. 
 
Reactive Oxygen Species 
Increasing ROS content within muscle cells can have a significant effect on the 
apoptotic signaling within skeletal muscle. Mitochondrial ROS have been proposed to initiate 
early apoptotic signaling events. For example, ROS can directly interact with and facilitate 
mtPTP opening [97] resulting in release of cytochrome c or AIF from the mitochondria [1,14]. 
Reactive oxygen species also indirectly influence the apoptotic pathway by activating mitogen-
activated protein kinases and various redox-sensitive transcription factors involved in the 
expression of both anti-apoptotic and pro-apoptotic genes [98]. 
  It has been demonstrated that endurance training results in reduced ROS production 
and increased NF-κB activation [99].  Decreased ROS production could help reduce activation 
of the intrinsic pathway of apoptosis and increased NF-κB activation could result in increased 
transcriptional activation of anti-apoptotic proteins thereby further protecting the muscle from 
apoptotic cell death. The decreases in ROS production could possibly be mediated by increased 
mitochondrial content within the cell that results from endurance training. Caloric restriction 
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models have been shown to increase mitochondrial content [48,77,78]  as well as reduce ROS 
production and enhance metabolic efficiency in liver [78] and in skeletal muscle [100]. 
Collectively, these data suggest that increased mitochondrial content may enhance cellular 
energy efficiency resulting in the production of less ROS.   
 
Calcium Homeostasis 
Mitochondrial biogenesis may also mediate apoptotic signaling by mediating calcium 
homeostasis within the cell. Mitochondria act as a ‗calcium sink‘ to buffer intracellular 
concentrations by up-taking free calcium from the cytosol. Too much calcium intake can lead 
to mitochondrial swelling and pore formation or bursting of the mitochondria leading to 
apoptosis through the release of pro-apoptotic proteins such as cytochrome c and AIF.  Bianchi 
et al. [101] determined that increasing mitochondrial content resulted in a significant decrease 
in calcium induced apoptosis.  Therefore, increased mitochondrial content may allow for 
increased calcium buffering capacity resulting in a decreased susceptibility to calcium induced 
apoptosis.   
 
Project Objectives             
Examination of the literature shows that the muscle degeneration observed in some of 
these states can be attenuated with exercise training and caloric restriction [95,103].  A 
common adaptation seen in skeletal muscle following both exercise training and caloric 
restriction is the upregulation of mitochondrial content [48,51,58,77].  Though the relationship 
between endurance training and apoptosis has been examined in rodent models, the specific 
effect of mitochondrial biogenesis on apoptotic signaling has not been examined. Thus, the 
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purpose of this project is to specifically examine the effect of mitochondrial biogenesis using a 
cell culture approach. To accomplish this, L6 myocytes will be cultured under a number of 
conditions to induce mitochondrial biogenesis. Cells will then be administered several 
apoptotic stimuli and be examined for changes in apoptotic markers and signaling events. 
 
Hypotheses 
 Examination of the literature on regulation of mitochondrial biogenesis revealed that 
both AMPK
 
and NO play significant roles in this process. Given that studies have 
reported that both the AMPK activator, AICAR, and the NO donor, SNAP, induce 
mitochondrial biogenesis in L6 myoblasts and myotubes, it is expected that 
mitochondrial biogenesis will be successfully induced with both agents. We expect to 
see increases in all four of the mitochondrial biogenesis/content markers PGC-1α, 
cytochrome c, AIF, and MnSOD. 
 Upon review of the literature, it can be shown a relationship between mitochondrial 
content and skeletal muscle apoptosis may exist. Therefore, it is expected that 
increasing mitochondrial content by intermittent SNAP and AICAR treatment will 
result in decreased apoptotic cell death in response to apoptotic stimuli as determined 
AnnexinV-FITC/PI staining, cell cycle analysis, and cell size/counting analysis. 
 Similarly, it is hypothesized that caspase-3 and caspase-9 activity will be reduced in the 
biogenesis groups following exposure to apoptotic stimuli 
 Increasing mitochondrial content has been associated with decreased ROS production. 
Therefore it is hypothesized that following mitochondrial biogenesis mitochondrial 
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specific ROS generation as well as total cellular ROS generation will be reduced in 
comparison to control cells. 
 Staurosporine induces apoptosis through it actions as a global cellular kinase inhibitor 
and the exact pathway by which it induces apoptosis is currently unknown.  However, 
one study using a PGC-1α overexpression model to increase mitochondrial content 
found that the PGC-1α overexpressing cells were not protected against staurosporine 
induced cell death but were protected against C2-ceramide induced cell death. 
Therefore, it is hypothesized, that increasing mitochondrial content in L6 myoblast by 
SNAP and AICAR treatment will protect against hydrogen peroxide- and C2-ceramide-

















Cell Culture and Treatments 
L6 rat myoblast were cultured in low glucose Delbecco‘s Modified Eagles Medium 
(DMEM - ThermoScientific) containing 10% fetal bovine serum (ThermoScientific) and 1% 
penicillin and streptomycin (ThermoScientific) on 60 mm polystyrine cell culture dishes (BD 
biosciences). Cells were kept in continuous passage by trypsinization (0.25% trypsin - 
ThermoScientfic) of subconfluent cultures. Cells used were between passages 3 to 10. For 
experiments, cells were seeded at a density of 150,000 cells per dish.  Cells were allowed to 
adhere to the dish surface and grow for 24 hours at which point cells were washed twice with 
calcium and magnesium free phosphate buffered saline (PBS) and media replaced.  To induce 
mitochondrial biogenesis, two different treatments were then administered as described by 
Wadley et al. [71]: No treatment (control), 100µM of the NO donor, S-nitroso-N-
acetylpenicillamine (SNAP - Invitrogen) diluted in ethanol, and 2mM of the AMPK activator, 
5-Aminoimidazole-4-carboxamide-ribonucleoside (AICAR -Toronto Research Chemicals) 
diluted in culture medium. Treatments were applied for 5 hours per day for 5 days in the same 
growth media. After each 5 hour treatment media was aspirated and cells were washed twice 
with PBS to remove any remaining drugs and fresh pre-warmed media was then added to each 
dish.  Each experiment was repeated on 5 separate occasions in duplicate. 
  
Induction of Apoptosis 
To evaluate the affect of increased mitochondrial content on apoptotic susceptibility, 
apoptosis was induced by treating cells with three different apoptotic stimuli: Staurosporine 
and C2-ceramide as described by Bianchi et al. [101], and Hydrogen Peroxide (H2O2) as 
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described by Alway et al. [103]. To determine appropriate concentration of apoptotic stimuli, a 
concentration curve was produced. Staurosporine was administered at a concentration 2µM for 
4 hours while H2O2 and C2-ceramide were administered at a concentration of 2mM and 50μM 
for 24 hours. Apoptosis was induced approximately 18 hours following the last 5 hour 
treatment. After administration of the apoptosis inducing agents the media was collected and 
the remaining adherent cells were harvested by using 0.25% trypsin.   
 
Cell Counting/Size Analysis 
Cell counts were performed on each treatment group as well as apoptosis induced 
groups to determine the concentration of cells. Briefly, isolated cells were resuspended in 4mL 
of growth media. Using the Z2 Coulter Counter (Beckman-Coulter), cells between 10-18µm 
were counted (as viable cells) and cell concentration was determined. A second count was then 
made of cells between 5-10um as representation of apoptotic cells. The quantity of apoptotic 
cells was then expressed as a percentage of the total cell population and normalized to control 
cells. 
 
Flow cytometry  
Mitochondrial ROS Production 
MitoSOX Red is a highly selective mitochondrial superoxide indicator and was used to 
evaluate mitochondrial ROS production in the treatment groups. Briefly, 500,000 cells of each 
treatment group were aliquoted into separate tubes. Cells were then centrifuged at 1000g for 4 
minutes. Supernatant was removed and cell pellet was resuspended in 500μL of PBS. 
MitoSOX Red was then added to each sample to a final concentration of 5µM and incubated in 
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the dark at 37
o
C for 30 minutes. Cells were then centrifuged and washed twice with PBS. 
MitoSOX fluorescence was then measured by flow cytometry (FACSCalibur, BD Bioscience) 
and analyzed using Cell Quest Pro software (BD Bioscience). 
 
Total Cell ROS Production 
Total cell ROS generation was determined using 2‘,7‘dichlorohydrofluorescein-diacetate 
(DCFH-DA). DCFH-DA is hydrolyzed by intracellular esterases to yield the nonfluorescent 
DCFH. DCFH is then oxidized by exposure to cellular ROS to the highly fluorescent 
compound DCF.  Briefly, 500000 cells were resuspended in PBS and DCFH-DA (Invitrogen) 
was added to a final concentration of 10µM and then incubated in the dark for 15 minutes at 
37˚C. Samples were then washed twice with PBS and DCF fluorescence was measured by flow 
cytometry.  
Annexin V-FITC and PI Apoptosis Assay   
Annexin V-FITC is a fluorescent protein that binds to phosphotidylserines that appear on the 
membrane at the initiation of apoptosis while propidium iodide (PI) is a fluorescent dye that 
binds to nuclear DNA following rupture of the cell membrane. Isolated cells were washed in 
PBS and then resuspended and in Annexin Binding Buffer (Hepes buffer: 10 mM 
HEPES/NaOH, pH 7.4, 150 mM NaCl, 1.8 mM CaCl2). Cells were then counted and 




 cells were 
then aloquoted into to tubes. 5 L of Annexin V-FITC and 10µL of 50µg/mL PI were then 
added to the tubes.  Cells were incubated in the dark for 15 minutes at room temperature after 
which 400µL of Annexin Binding Buffer was added. AnnexinV-FITC and PI fluorescence was 
then measured by flow cytometry.  
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Cell Cycle Assay 
Cells were harvested by 0.25% trypsinization as described above. Cells were then centrifuged 
at 1000g for 5 minutes and then washed twice with PBS and resuspended in PBS. Cells were 
then counted and 2 x 10
6
 cells were aliquoted into new tubes. Cells were then centrifuged at 
1000g for 5 minutes and supernatant was removed (approximately 100µL of supernatant was 
left in the bottom of the tube with cells to allow for easier suspension in 70% ethanol). Cells 
were gently vortexed and while vortexing, 1mL of ice cold 70% ethanol was slowly added to 
the tube to fix the cells. Cells were fixed for at least 24 hours. Following fixation, cells were 
centrifuged at 1000g for 5 minutes. The supernatant was removed and cells were washed twice 
with PBS.  100µL of RNAase was then added along with 400µL of propidium iodide solution 
(50µg/mL in PBS containing 0.1% TritonX).  Cells were then incubated in the dark at room 
temperature for 30 minutes.  PI fluorescence was then measured using flow cytometry.   
 
Analysis of Total Cellular Protein Content 
Isolated cells were centrifuged at 1000g for 4 minutes. Cells were then washed with ice 
cold PBS and centrifuged one more time at 1000g for 4 minutes. Supernatant was removed and 
cells were lysed using a buffer containing 20mM HEPES, 10mM NaCl, 1.5mM MgCl, 1 mM 
DTT, 20% glycerol and 0.1% Triton X100; pH 7.4  with protease inhibitors (Complete 
Cocktail; Roche Diagnostics) and homogenized by hand using a plastic homogenizer. 






Western Blot Analysis 
Aliquots of homogenate were loaded in duplicate on 10-15% SDS-PAGE gels such that 
each sample contained an equal amount of protein (concentration curves were detected to 
determine appropriate amount of protein to load for detections). Gels were transferred onto 
PVDF membrane (Bio-Rad Laboratories) and blocked with 5% milk in Tris-buffered Saline 
with 0.1% Tween (TBS-T) for 1 hour at room temperature or overnight at 4˚C. The blots were 
probed with primary antibodies at room temperature for 1 hour or overnight at 4
o
C.  To verify 
increased mitochondrial content, the following primary antibodies were used:  mouse 
monoclonal anti-cytochrome c, rabbit polyclonal anti-PGC-1, mouse monoclonal anti-AIF 
(Santa Cruz Biotechnology)rabbit polyclonal anti-Manganese Superoxide Dismutase 
(MnSOD)(Stressgen Bioreagents). To evaluate apoptotic characteristics following treatment of 
apoptotic stimuli the following primary antibodies were used: rabbit polyclonal anti-ARC, 
mouse monoclonal anti-Heat Shock Protein 70 (Hsp70) (Stressgen Bioreagents); rabbit 
polyclonal anti-Second Mitochondrial Activator of Caspases (Smac) (Assay Designs), rabbit 
polyclonal anti-Bax (Santa Cruz), mouse monoclonal anti-Bcl-2 (Santa Cruz), mouse 
monoclonal anti-XIAP (Stressgen), rabbit polyclonal anti-catalase (Chemicon), and rabbit 
polyclonal anti-Copper Zinc Superoxide Dismutase (CuZnSOD)(Stressgen). Following 
incubation of primary antibody, membranes were washed with TBS-T and incubated with the 
corresponding horseradish peroxidase (HRP)-conjugated secondary antibody for 1-2 hours at 
room temperature. Membranes were then washed with TBS-T and visualized using Amersham 
Enhanced Chemiluminescence Western Blotting detection reagents (GE Healthcare) and the 
ChemiGenius 2 Bio-Imaging System (Syngene).  Protein levels are expressed as mean optical 
density with arbitrary units and the molecular weights of the proteins was determined using 
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Precision Plus Protein WesternC Standards in conjunction with Precision Protein Streptactin 
HRP Conjugate (BioRad Laboratories). For verification of equal protein loading, membranes 
were evaluated with Ponceau S staining (Sigma-Aldrich). 
 
Fluorometric Caspase Activity Assay: 
To determine the enzyme activity for caspase-3, caspase-8, and caspase-9, a 
spectrofluorometric assay of cell homogenate was performed. Isolated cells were homogenized 
in ice cold muscle lysis buffer without protease inhibitor cocktail. The homogenate was then 
centrifuged at 1000 g for 4 minutes at 4
o
C and the remaining pellet was discarded.  To 
determine caspase-3 and -9 activities, supernatants were then incubated in duplicate on a 96 
well plate for two hours using the following fluorescent substrates Ac-DEVD-AMC (Alexis 
Biochemicals) for caspase-3 and Ac-LEHD-AMC (Alexis Biochemicals) for caspase-9.  These 
substrates are weakly fluorescent but fluorescence increases dramatically following proteolytic 
cleavage by their corresponding active caspase. Fluorescence was measured using a 
SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices) with an 
excitation wavelength of 360nm and an emission wavelength of 440nm. Human recombinant 
active caspase-3 and -9 (Alexis Biochemicals) was loaded as a positive control for caspase 
activity. Inhibitors for caspase-3(Ac-DEVD-CHO, Alexis Biochemicals), and caspase-9 (Ac-
LEHD-AMC, Alexis Biochemicals) were also run to verify substrate specificity. Caspase 
activity was then normalized to total protein content and expressed as mean fluorescence 






Comparisons were made only between control cells and SNAP-treated cells or controls 
cells and AICAR-treated cells. No comparisons were made between SNAP-treated cells and 
AICAR-treated cells. Additionally no comparisons were made between the apoptotic-inducing 
agents staurosporine, H2O2, or C2-ceramide. Values are expressed as means ± SE relative to 
control cells. Statistically significant differences were determined using paired Student‘s t-





















 For induction of mitochondrial biogenesis, L6 myoblasts were left untreated or treated 
for 5 hours/day over 5 days with either 2mM AICAR or 100μM SNAP. Pilot studies performed 
using these dosages on L6 myoblast resulted in increased mitochondrial biogenesis (see 
appendix). In the present study, the levels of several mitochondrial content/biogenesis markers 
were increased following acute treatment with AICAR and SNAP.  AICAR increased the 
protein content of peroxisome proliferator-activated receptor (PPAR)-γ coactivator-1α (PGC-
1α) by 36%, cytochrome c by 71%, apoptosis inducing factor (AIF) by 19%, and manganese 
superoxide dismutase (MnSOD) by 26% (Fig. 4). Similarly, SNAP increased the protein 
content of PGC-1α by 34%, cytochrome c by 20%, AIF by 19%, and MnSOD by 22% (Fig. 4).  
In addition, to verify that SNAP and AICAR successfully induced mitochondrial biogenesis, 




Figure 4. Mitochondrial Biogenesis Markers.  Representative western blot and 
corresponding analysis of the mitochondrial biogenesis proteins/markers PGC-1, cytochrome c, 
AIF, and MnSOD following intermittent exposure (5 hrs/day for 5 days) to the nitric oxide 




Mitochondrial ROS Production 
Mitochondrial specific ROS production was evaluated using a highly selective 
mitochondrial superoxide indicator dye, MitoSOX red.  MitoSOX red fluorescence in all cells 
was then measured by flow cytometry and values were expressed relative to control cells. 
Under basal conditions (not treated with apoptotic inducing agent), MitoSOX fluorescence was 
not significantly different between controls, SNAP, or AICAR treated cells (Fig. 5). In cells 
33 
 
induced to undergo apoptosis with staurosporine and C2-ceramide, there was no significant 
difference between control cells and SNAP- or AICAR-treated cells. Interestingly, when cells 
were induced to undergo apoptosis using H2O2, MitoSOX fluorescence was significantly 
increased (p<0.05) by 23% in AICAR-treated cells compared to control cells, whereas 
MitoSOX fluorescence in SNAP-treated cells was not significantly different from control cells 
(Fig. 5).  
 
Figure 5. MitoSOX Fluorescence - Mitochondrial ROS Production Following 
Mitochondrial Biogenesis and Exposure to Apoptotic Stimuli. Mitochondrial ROS 
production as determined by MitoSOX fluorescence under basal conditions (A), and following 
4 hours exposure to 2μM staurosporine (B), 24 hours exposure to 2mM H2O2 (C), or 24 hours 
exposure to 50μM C2-ceramide. * p<0.05 relative to CTRL cells within a particular apoptosis-




Total ROS Production 
To determine if induction of mitochondrial biogenesis alters total cellular ROS, the 
ROS-reactive dye, DCFH-DA was utilized and fluorescence was measured by flow cytometry. 
Interestingly, under basal conditions AICAR-treated cells showed a trend towards increased 
ROS production with a 23% increase in DCF fluorescence, however, this did not reach 
statistical significance (p=0.06) (Fig. 6).  DCF fluorescence was significantly elevated (p<0.05) 
by 39% in AICAR-treated cells compared to controls treated with staurosporine (Fig. 6). 
Although not statistically significant (p=0.075), DCF fluorescence in SNAP-treated cells was 
increased by 24% compared to control cells following exposure to staurosporine (Fig 6.). DCF 
fluorescence was not found to be significantly different between control cells and SNAP- or 
AICAR-treated cells following exposure to H2O2 and C2-ceramide. Interestingly, following 
exposure to staurosporine and H2O2, DCF fluorescence was significantly lower in control cells 
and SNAP-treated cells compared to basal controls.  
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Figure 6. DCF Fluorescence - Total Cellular ROS Production Following Mitochondrial 
Biogenesis and Exposure to Apoptotic Stimuli. Total cell ROS generation as determined by 
mean DCF fluorescence under basal conditions (A) and following 4 hours exposure to 2μM 
staurosporine (B), 24 hours exposure to 2mM H2O2 (C), or 24 hours exposure to 50μM C2-
ceramide.  * p<0.05 relative to CTRL within a particular apoptosis-inducing condition. # 
p<0.05 relative to Basal CTRL. (n=5) 
 
AnnexinV- FITC and Propidium Iodide Staining 
To determine the proportion of apoptotic cells, the L6 myoblasts were stained with 
AnnexinV-FITC and propidium iodide. Cells expressing no fluorescence (AnnexinV-/PI-) 
were categorized as healthy. In the early stages of apoptosis, cells begin to express 
phosphatidylserine on their membrane. AnnexinV-FITC will then bind to the 
phosphatidylserines (AnnexinV+/PI-) and are categorized as early apoptotic. As apoptosis 
progresses, the cell membrane ruptures and allows propidium iodide to bind to the DNA, as 
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such, these cells will emit fluorescence. These cells which express both AnnexinV and 
propidium iodide fluorescence (AnnexinV+/PI+) were categorized as late apoptotic (see 
appendix B). Pilot studies using L6 myoblasts showed that treatment with increasing 
concentrations of staurosporine, H2O2, and C2-ceramide resulted in increasing proportion of 
early and late apoptotic cells (see appendix A).  These data were used to find the appropriate 
concentrations of staurosporine, H2O2, and C2-ceramide to induce apoptosis. The percentage of 
healthy cells in AICAR-treated cells following staurosporine, H2O2, and C2-ceramide exposure 
were 70%, 77%, and 78%, respectively, and was significantly higher (p<0.05) compared to the 
54%, 71%, and 72% observed in control cells within a particular apoptosis-inducing condition, 
respectively (Fig. 7). Additionally, the percentage of early apoptotic cells in AICAR-treated 
cells following staurosporine, H2O2, and C2-ceramide exposure were 18%, 10%, and 10%, 
respectively, and was significantly lower (p<0.05) compared to the 31%, 16%, and 13% 
observed in the control cells within a particular apoptosis-inducing condition, respectively (Fig. 
7). Similarly, the percentage of late apoptotic cells (AnnexinV+/PI+) were 6% and 10% 
following staurosporine and C2-ceramide exposure, respectively, which was significantly lower 
(p<0.05) than the percentage  observed in the control cells (7%, and 11%, respectively) within 
a particular apoptosis-inducing condition, respectively (Fig. 7). SNAP-treated cells were also 
protected against staurosporine-, H2O2-, and C2-ceramide-induced apoptosis with the 
percentage of early apoptotic cells (24%, 12%, and 12%, respectively) being significantly 
lower (p<0.05) than the percentage of early apoptotic cells (31%, 16%, and 13%, respectively) 
in control cells within a particular apoptosis-inducing condition (Fig. 7). SNAP-treated cells 
also had significantly lower (p<0.05) percentage of late apoptotic cells (6%) compared to the 
percentage of late apoptotic cells in control cells (7%) following exposure to staurosporine 
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(Fig.7). The percentage of late apoptotic cells following exposure to C2-ceramide also tended 
to be lower (p=0.062) in SNAP-treated cells compared to control cells. Additionally, the 
percentage of healthy cells following staurosporine, H2O2, and C2-ceramide (64%, 75%, and 
77%, respectively) was significantly higher (p<0.05) in SNAP-treated cells when compared to 
the percentage of healthy cells (54%, 71%, and 72%, respectively) in the control cells within a 
particular apoptosis-inducing condition (Fig. 7).  
Figure 7. AnnexinV-FITC/PI Staining Following Apoptotic Stimuli. Proportion of healthy 
(AnnexinV-/PI-), early apoptotic (AnnexinV+/PI-), and late apoptotic (AnnexinV+/PI+). Cells 
were analyzed under basal conditions (A), and following exposure to 2μM staurosporine for 4 
hours (B), 2mM H2O2 for 24 hours (C), or 50μM C2-ceramide for 24 hours (D). * p<0.05 






Cell Counting/Size Analysis 
 Cell counts were performed to determine the concentration of suspended cells. Cells 
between 10-18µm were counted (as viable cells) and cell concentration was determined. A 
second count was then made of cells between 5-10μm likely representing apoptotic cells. 
SNAP treatment significantly lowered (p<0.05) the percentage of apoptotic cells compared to 
controls under basal conditions. Additionally, following exposure to staurosporine, H2O2, and 
C2-ceramide, the percentage of apoptotic cells (50.7%, 24.3%, and 27.3%, respectively) was 
significantly lower (p<0.05) in SNAP-treated cells compared to the percentage of apoptotic 
cells  (52.6%, 30.3%, and 32%, respectively) in control cells within a particular apoptosis-
inducing condition (Fig. 8). Similarly, AICAR treatment resulted in significantly lower 
(p<0.05) percentage of apoptotic cells (25.5% and 27%) following H2O2 and C2-ceramide 
exposure, respectively, compared to the percentage of apoptotic cells (30.3% and 32%, 
respectively) in control cells within a particular apoptosis-inducing condition (Fig. 8). There 
were no significant differences in the percent of apoptotic cells between control cells and 





Figure 8. Cell Count / Size Analysis Following Exposure to Apoptotic Stimuli. Proportion 
of apoptotic cells under basal conditions (A) and following exposure to 2μM staurosporine for 
4 hours (B), 2mM H2O2 for 24 hours (C), or 50μM  C2-ceramide for 24 hours (D).  * p<0.05 
relative to CTRL within a particular apoptosis-inducing condition. (n=5) 
 
 
Caspase Activity Assay 
 
To determine the enzyme activity for caspase-3 and caspase-9, a spectrofluorometric 
assay of cell lysates was performed. Pilot studies using L6 myoblasts showed that increasing 
concentrations of staurosporine or H2O2 leads to a step-wise increase in caspase-3 activity (see 
appendix A). In the current study, under basal conditions, there were no significant differences 
in caspase-3 or caspase-9 activity in SNAP-, or AICAR- treated cells in comparison to controls 
(Fig. 9,10). Exposure to staurosporine, H2O2, and C2-ceramide resulted in a significant increase 
(p<0.05) in caspase-3 activity in all cells compared to basal controls (Fig. 9). Similarly, 
exposure to the apoptosis inducing agents elevated caspase-9 activity, however, this was only 
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significant (p<0.05) in all cells following staurosporine exposure and in control cells following 
C2-ceramide exposure (Fig. 10).  Additionally, following exposure to staurosporine and C2-
ceramide, caspase-3 activity was significantly reduced (p<0.05) by 16% and 19% in the SNAP-
treated cells compared to their respective control cells (Fig. 9). Similarly, in cells treated with 
SNAP, caspase-9 activity was significantly reduced (p<0.05) by 18% and 17% compared to 
control cells following exposure to staurosporine and C2-ceramide, respectively (Fig. 10).  In 
cells treated with AICAR, caspase-3 activity was significantly decreased (p<0.05) by 27% and 
17% compared to control cells following exposure to staurosporine and C2-ceramide, 
respectively (Fig. 9). Additionally, caspase-9 activity was significantly reduced (p<0.05) by 
20% in AICAR-treated cells when compared to controls treated with staurosporine (Fig. 10). 
No significant differences in caspase-3 or caspase-9 activity were found in SNAP- or AICAR-






















Figure 9. Caspase-3 Activity Following Mitochondrial Biogenesis and Exposure to 
Apoptotic Stimuli. Caspase-3 activity under basal conditions (A) and following exposure to 
2μM staurosporine for 4 hours (B), 2mM H2O2 for 24hrs (C), or 50μM C2-ceramide for 24 
hours (D).  * p<0.05 relative to CTRL within a particular apoptosis-inducing condition. # 




Figure 10. Caspase-9 Activity Following Mitochondrial Biogenesis and Exposure to 
Apoptotic Stimuli. Caspase-9 activity under basal conditions following mitochondrial 
biogenesis (A) and following exposure to 2μM staurosporine for 4 hours (B), 2mM H2O2 for 
24hrs (C), or 50μM C2-ceramide for 24 hours (D).  * p<0.05 relative to CTRL within a 
particular apoptosis-inducing condition. # p<0.05 relative to Basal CTRL. (n=5) 
 
 
Western Blot Analysis  
Antioxidants 
To examine the antioxidant capacity of the cells, the proteins Catalase, MnSOD, and 
CuZnSOD were examined. In healthy cells, Catalase expression was increased (p<0.05) by 
27% and 23% in SNAP- and AICAR-treated cells, respectively, when compared to control 
cells (Fig.11). Additionally, Catalase expression was significantly elevated (p<0.05) by 17% 
43 
 
and 26% in SNAP- and AICAR-treated cells, respectively, compared to control cells when 
exposed to staurosporine (Fig.11). Catalase expression was not significantly different between 
groups following exposure to H2O2 or C2-ceramide (Fig.11). As previously stated, MnSOD 
content under basal conditions was significantly elevated (p<0.05) by 22% and 26% in SNAP- 
and AICAR-treated cells, respectively, compared to untreated control cells. MnSOD 
expression was not significantly different between groups following exposure to staurosporine, 
H2O2 or C2-ceramide (Fig.11).  Similarly, CuZnSOD expression was not significantly different 
between groups under basal conditions or following staurosporine and C2-ceramide (Fig.11). 
However, CuZnSOD expression was found to be significantly lower (p<0.05) by 17% in the 
SNAP-treated cells following H2O2 exposure, whereas there was no change in AICAR-treated 






Figure 11. Relative Antioxidant Protein Content Following Mitochondrial Biogenesis and 
Exposure to Apoptotic Stimuli. Western blot analysis and representative blots of the 
antioxidants Catalase, MnSOD, and CuZnSOD under basal conditions (A) and following 
exposure to 2μM staurosporine for 4 hours (B), 2mM H2O2 for 24 hours (C), or 50μM C2-
ceramide for 24 hours (D). *p<0.05 relative to CTRL within a particular apoptosis-inducing 




ARC expression in the AICAR-treated cells was not significantly different from control 
cells under basal conditions or following exposure to H2O2 and C2-ceramide (Fig. 12).  
However, ARC expression was 13% (p=0.07) lower in the AICAR-treated cells in comparison 
to control cells following staurosporine treatment (Fig. 12). ARC expression in SNAP-treated 
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cells was not significantly different from controls under basal conditions (Fig. 12). 
Interestingly, ARC expression was significantly lower (p<0.05) by 14% in SNAP-treated cells 
compared to control cells following exposure to H2O2.  Similarly, ARC expression was reduced 
20% (p=0.07) and 23% (p=0.06) in SNAP-treated cells compared to control cells following 
staurosporine and C2-ceramide exposure, respectively (Fig. 12).  
Under basal conditions, XIAP expression was not different in SNAP or AICAR treated 
cells when compared to controls (Fig. 12). Exposure to the apoptotic stimulants resulted in 
degradation of XIAP, such that XIAP could not be sufficiently detected via western blot 
analysis.  
Bcl-2 expression was not different in AICAR-treated cells compared to control cells 
under any condition (Fig. 12). Interestingly, under basal conditions, Bcl-2 expression was 24% 
higher (p=0.054) in SNAP-treated cells compared to controls (Fig. 12). Similarly, Bcl-2 
expression was significantly higher (p<0.05) by 7% in SNAP-treated cells following exposure 
to H2O2 (Fig. 12). There was no difference in Bcl-2 expression between SNAP treated cells and 
controls following staurosporine and C2-ceramide exposure (Fig. 12). 
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Figure 12. Relative Anti-Apoptoic Protein Content Following Mitochondrial Biogenesis 
and Apoptotic Stimuli. Western blot analysis of anti-apoptotic proteins ARC, Bcl-2, and 
XIAP under basal conditions (A) and following exposure to 2μM staurosporine for 4 hours (B), 
2mM H2O2 for 24 hours (C), or 50μM C2-ceramide for 24 hours (D). *p<0.05 relative to CTRL 




Bax content was not significantly different in SNAP- or AICAR-treated cells in 
comparison to control cells following mitochondrial biogenesis (basal) or exposure to all 
apoptotic stimuli (Fig. 13). Under basal conditions, the pro-apoptotic protein SMAC was not 
significantly different from controls in SNAP-treated cells but was 14% higher (p<0.05) in 
AICAR-treated cells. SMAC content was not significantly different from controls in SNAP- or 
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AICAR-treated cells following exposure to staurosporine and H2O2 (Fig. 13). However, SMAC 
content was 19% (p=0.08) and 21% (p=0.1) lower in SNAP and AICAR groups, respectively, 
compared to controls following exposure to C2-ceramide (Fig. 13). As previously stated, under 
basal conditions AIF content was significantly elevated (p<0.05) by 19% in both SNAP- and 
AICAR-treated cells compared to untreated control cells.  However, AIF content was not 
significantly different from control cells in SNAP- or AICAR-treated cells following exposure 
to staurosporine, H2O2, or C2-ceramide (Fig. 13).  
 
Figure 13. Relative Pro-Apoptotic Protein Content Following Mitochondrial  
Biogenesis and Exposure to Apoptotic Stimuli.  Representative western blots and analysis of 
the pro-apoptotic proteins Bax, SMAC, and AIF under basal conditions (A) and following 
exposure to 2μM staurosporine for 4 hours (B), 2mM H2O2 for 24 hours (C), and 50μM C2-
ceramide for 24 hours (D). *p<0.05 relative to CTRL within a particular apoptosis-inducing 
condition. # p<0.05 relative to Basal CTRL. (n=5) 
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Cell Cycle Analysis of Apoptotic Cells 
 
Cell cycle analysis was performed as another measure to examine the proportion of 
apoptotic cells. Under basal conditions, the proportion of apoptotic cells was not significantly 
different in SNAP or AICAR treated cells compared to controls (Fig. 14).  Following exposure 
to staurosporine and H2O2, the percentage of apoptotic cells was not significantly different in 
SNAP- or AICAR-treated cells compared to control cells. The proportion of apoptotic cells 
was significantly lower (p<0.05) in SNAP- and AICAR-treated cells compared to controls 






Figure 14. Cell Cycle Analysis of Apoptotic Cells Following Mitochondrial Biogenesis and 
Exposure to Apoptotic Stimuli.  Cell cycle analysis of apoptotic cell population under basal 
conditions (A) and following exposure to 2μM staurosporine for 4 hours (B), 2mM H2O2 for 
24 hours (C), or 50μM C2-ceramide for 24 hours (D).  * p<0.05 relative to CTRL cells within a 





















Apoptosis plays a large role in many degenerative skeletal muscle states, including 
motor nerve denervation, atrophy due to immobilization, and Duchenne muscular dystrophy 
[1,38].  There is also evidence indicating that dysregulation of apoptotic signaling plays a key 
role in the pathophysiology of skeletal muscle cell loss with age [33]. Examination of the 
literature shows that the muscle degeneration observed in some of these states can be 
attenuated with exercise training and caloric restriction [94,102].  A common adaptation seen 
in skeletal muscle following both exercise training and caloric restriction is the upregulation of 
mitochondrial content
49,52,59,78
.  Therefore, the purpose of the current study was to examine 
whether increasing mitochondrial content can provide protection against apoptosis. To isolate 
this potential mechanism we utilized a cell culture approach in rat L6 myoblasts. 
 
Mitochondrial Biogenesis 
In the present study, the NO donor SNAP and the AMPK activator AICAR were used 
to induce mitochondrial biogenesis. In addition, this study used intermittent exposure to SNAP 
and AICAR (5 hours/day for 5 days) which we feel is more physiological than others who have 
used stable overexpression of PGC-1α [55] which results in 2.5-fold increase in mitochondrial 
content. Exercise and caloric restriction studies have demonstrated NO‘s role in mitochondrial 
biogenesis through increased activation of eNOS [48,77,78].  Confirming NO‘s role in 
mitochondrial biogenesis is the finding that eNOS knockout animals have reduced 
mitochondrial content within skeletal muscle [77,80,81].  Furthermore, in cell culture models, 
it has been demonstrated that NO induces mitochondrial biogenesis through a cGMP mediated 
pathway that results in elevation of PGC-1α [80].  In the present study, we found that 
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intermittent exposure of L6 myoblasts to SNAP significantly increased the protein content of 
PGC-1 by 1.34 fold, cytochrome c by 1.2 fold, AIF by 1.19 fold, and MnSOD by 1.22 fold, 
indicating mitochondrial biogenesis and content was significantly elevated. These findings are 
in agreement with other cell culture studies which have used SNAP to induce mitochondrial 
biogenesis. For example, McConnel et al. [71] showed that treatment of L6 myotubes with 
SNAP significantly increased the protein expression of PGC-1α and the mitochondrial markers 
COXI and COXIV by up to 2-fold.  Furthermore, cell culture studies in human, rat, and mouse 
myoblasts and myotubes have shown that intermittent administration of NO donors (SNAP or 
DETA-NO) results in increased PGC-1α and NRF-1 mRNA content and protein expression, as 
well as increased expression of other mitochondrial markers such as cytochrome c, COXI, 
COXIV, and mtTFA [71,77,80].   
AICAR mediates mitochondrial biogenesis through activation of AMPK. Exercise and 
cell culture studies suggest that AMPK works by activation and elevation of PGC-1α to induce 
mitochondrial biogenesis [72]. In addition, AMPK activation has been shown to result in the 
deacetylation of PGC-1α resulting in its activation [104]. The effect of AICAR administration 
on AMPK signaling and mitochondrial biogenesis has been well established. For example, 
Ojuka et al. [69] demonstrate that exposing L6 myotubes to AICAR results in significantly 
elevated AMPK phosphorylation.  In addition, this group and others have shown that exposure 
of L6 myoblasts to AICAR results in significant increases in the mitochondrial markers ALAS, 
cytochrome c, PGC-1α, COXI and COXIV protein expression relative to untreated control 
cells [69,70,71].  The current study is in agreement with these findings as we found that acute 
treatment with AICAR significantly increased the content of PGC-1, cytochrome c, AIF, and 
MnSOD by 1.36, 1.71, 1.19 and 1.26 fold, respectively. Collectively, these results demonstrate 
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that intermittent exposure to SNAP and AICAR successfully increased mitochondrial 
biogenesis and content in the L6 myoblasts used in the present study.  
 
Basal Antioxidants, ROS, and Apoptotic Signaling Following Mitochondrial Biogenesis   
Although excessive apoptosis has been shown to play a role in a variety of disease 
states [5,106,6]  and muscle atrophy [38,39], regular exercise training as been associated with 
decreased apoptosis [46,47,90,91] and improved basal levels of a number of apoptosis proteins 
[46,47,90,91]. As mentioned previously, exercise training has been established to induce 
mitochondrial biogenesis and it has been suggested that this increase in mitochondrial content 
could have an anti-apoptotic effect on skeletal muscle; however, this has not been 
systematically tested. In this study we show that under basal conditions, there is no difference 
between cells with higher mitochondrial content compared to control cells in the percentage of 
apoptotic cells measured. Consistent with this data, basal caspase-3 and -9 activities were not 
significantly different between biogenesis and control cells. However, caspase-3 activity 
tended to be reduced in SNAP-treated, although this did not reach statistical significance 
(p=0.09).   
We found similar results when examining the apoptotic signaling proteins. Basal levels 
of the anti-apoptotic proteins ARC, Bcl-2, and XIAP in the biogenesis treated cells were not 
significantly different from controls cells. Upon examination of the pro-apoptotic proteins, it 
was found that Bax protein content was not significantly different in biogenesis-treated cells 
compared to controls. However, AIF content was found to be significantly higher in both 
SNAP- and AICAR-treated groups while Smac protein content was significantly elevated in 
the AICAR-treated group but remained unchanged in SNAP-treated group. Although these 
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results may seem to indicate increased apoptotic signaling in these cells, it is likely that this is 
not the case. It is important to note that several apoptotic factors have dual roles providing both 
vital cellular functions and apoptotic signaling. For example, AIF resides in the mitochondria 
and plays a very important role in the electron transport chain [105,106].  It does not affect 
apoptotic signaling until receiving appropriate stimuli and is released from the mitochondria 
[105,106]. Since the cells are in a basal, healthy condition, it is likely that the increase in these 
proteins reflects the increase in mitochondrial content seen in both the SNAP- and AICAR–
treated groups. Therefore, these results indicated that induction of mitochondrial biogenesis by 
SNAP and AICAR does not alter basal apoptosis levels or the expression of key apoptotic 
proteins and enzymes.   
In contrast, the current study found that SNAP and AICAR treatment resulted in some 
modifications of the antioxidants under basal conditions. For example, catalase and MnSOD 
were significantly increased following 5 days of treatment with AICAR and SNAP.  However, 
we did not find any differences in CuZnSOD between groups. In transgenic mice, 
overexpression of PGC1-α has been shown to increase catalase activity and SOD2 content 
[107]. Similarly, Irrcher et al. [108] demonstrated that catalase mRNA levels were significantly 
increased after a single exposure to 1mM AICAR in C2C12 myotubes. Furthermore, in 
cultured endothelial cells Kukidome et al. [109] revealed that MnSOD mRNA was 
significantly elevated following exposure to AICAR.  In vivo and in vitro models using thyroid 
hormone to induce mitochondrial biogenesis have also shown increase in MnSOD content 
[110,111]. Endurance exercise training has also shown increased MnSOD expression with no 
change in catalase or CuZnSOD expression in skeletal muscle [112,113,114,115]. Since 
MnSOD is located only within the mitochondria, it is likely that the increases seen in MnSOD 
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content are due to a higher mitochondrial volume. Holloszy et al. [113] demonstrated that 
despite the increase in MnSOD, the ratio of SOD to mitochondria citrate cycle and respiratory 
chain enzymes were decreased, indicating that increased scavenging of superoxides is unlikely.  
Despite the increased MnSOD and catalase levels observed in the present study, total 
ROS generation (DCF fluorescence) was not decreased in mitochondrial biogenesis cells 
compared to control cells.  In fact, AICAR-treated cells showed a trend towards higher DCF 
fluorescence compared to controls. Mitochondrial specific ROS production (MitoSOX 
fluorescence) was not significantly different between mitochondrial biogenesis cells compared 
to control cells. It is possible that the dosage of SNAP and AICAR used resulted in increased 
ROS production. For example, Xu et al. [116] have shown that treatment of rat cardiomyocytes 
with 100μM SNAP results in significantly increased ROS production as determined by DCF 
fluorescence. Similarly, AICAR administration has also been shown to increase ROS 
production in neuroblastoma cells [117] and in pancreatic cells [118], AICAR administration 
has also been shown to increase ROS production. In contrast to these findings, Irrcher et al. 
[108] reported that 1mM AICAR treatment in C2C12 muscle cells for 24 hours resulted in 
significantly decreased ROS production compared to control cells.  In addition, conditions that 
lead to increased mitochondrial content in vivo (ie. calorie restriction) are associated with 
reduced ROS production [48,77,78]. It has been suggested that enhanced metabolic efficiency 
may be responsible for the reduced basal ROS production following mitochondrial biogenesis 
[79,101].  Interestingly, reduced ROS would be expected to decrease apoptosis in cells. In the 
present study, we did not find any differences in basal apoptosis or apoptotic signaling which is 




Induction of Apoptosis 
In the present study staurosporine, H2O2, and C2-ceramide, all activators of the intrinsic 
apoptotic pathway, were used to induce apoptosis in L6 myoblasts. Staurosporine is a global 
intracellular kinase inhibitor which has been shown to significantly increase both intracellular 
ROS and calcium concentrations [121,122]. Treatment of cells in culture with staurosporine 
invokes all the responses that are characteristic of apoptotic signaling (ie. cell shrinkage, 
caspase activation, DNA fragmentation) [120] and it has been well established as an apoptosis 
inducer in many cell types[120,121,122,123].  In rat cardiomyoctes, staurosporine has been 
shown to induce apoptosis in a dose dependent manner [120].  Yue et al. demonstrated that 
incubating cardiomyocytes with 0μM, 0.25μM, 0.5μM, and 1μM for 24hours, resulted in ~8%, 
15%, 30%, and 55% of the cells undergoing apoptosis [120]. They also found that caspase-3 
activity increased between 5-8 fold with increasing concentrations of staurosporine [120].  A 
similar dose-response relationship between staurosporine concentration and cell viability has 
also been shown in neuronal cell culture [124].  These results are consistent with the present 
findings where we show a dose-response relationship with staurosporine in both the proportion 
of apoptotic cells and activity of caspase-3.  The increased caspase-9 activity following 
staurosporine administration also indicates that staurosporine is likely acting not only through a 
caspase-dependant pathway but also through mitochondrial signaling which is consistent with 
the literature [122,125]. For example, it has been shown that staurosporine administration 
results in loss of mitochondrial membrane potential[121], release of pro-apoptotic proteins 
cytochrome c and Smac [123,124], and activation of caspase-3 and -9 [120,122,125]. It has 
also been demonstrated that caspase-dependent apoptosis can be inhibited using a variety of 
caspase inhibitors [122,125].  However, in these experiments, despite use of caspase inhibitors, 
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apoptosis was still shown to occur a short time later, indicating that a caspase-independent 
mechanism may also be involved [122,125].   Zhang et al. [122] show that staurosporine 
induces nuclear translocation of AIF to the nucleus despite caspase inhibition, suggesting AIF 
may be mediating the caspase-independent apoptosis. Although we did not measure AIF 
release or nuclear translocation, it is possible that staurosporine is acting through both a 
caspase-dependent and –independent mechanism.  
 H2O2 is commonly used to invoke oxidative stress and induce apoptosis in cell culture. 
Treatment of cells in culture with exogenous H2O2 results in cell death that exhibits all the 
classical signs of apoptosis such as cell shrinkage, caspase activation, and DNA fragmentation 
[103,126,127].  Exogenous H2O2 administration has been shown to induce apoptosis through 
the intrinsic apoptotic pathway in a variety of cell types [127,128,129,130].  It is thought that 
H2O2 initiates apoptosis by altering the mitochondrial permeability transition, possibly through 
Bax activation or free radical generation, allowing for cytochrome c release [128].  Studies 
have also shown that exogenous H2O2 can act on other intracellular structures, such as the 
endoplasmic reticulum, and invoke a sharp rise in intracellular calcium concentrations, which 
subsequently activates apoptotic pathways [131,132].  The results from this study show that 
exposing cells to increasing concentrations of H2O2 results in a step-wise increase in the 
number of apoptotic cells and caspase-3 activation.  We also show that exposure to H2O2 
results in elevation of the pro-apoptotic proteins Bax and Smac, as well as the anti-apoptotic 
protein Bcl-2. A study by Jiang et al. [133] showed that release of Smac from the mitochondria 
plays an important role in H2O2-induced cell death in C2C12 myoblasts. Exposure of cells to 
ROS has been shown to increase both pro-and anti-apoptotic proteins in various cell types 
[134,135].  It has been suggested that this occurs because a number of transcription factors can 
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be modulated by H2O2. For example, nuclear translocation of p53 can be caused by H2O2 [136], 
and the transcription factors, NFκB and AP-1 can be activated by H2O2 [135,137]. Once 
activated, these transcription factors can mediate transcription of both pro-apoptotic and anti-
apoptotic genes to either encourage apoptosis or attempt to rescue the cell from death 
[137,138,139]. 
Although H2O2 has been well established to induce apoptosis in a variety of cells, there 
is limited data examining the effect of H2O2 in skeletal muscle cells. Nevertheless, the results 
found in the current study correspond with the literature. For example, Stangel et al. [138] 
examined the potential of skeletal muscle myoblasts to undergo apoptosis when exposed to 
H2O2 and found increased number of TUNEL-positive nuclei and DNA fragmentation in a 
dose-dependent manner similar to the dose-response in apoptotic cells and caspase activity in 
the current study. More recently, studies by Caprossi et al. [127] and Siu et al. [103] have 
revealed the pathway by which H2O2 may induce apoptosis in skeletal muscle cells. They 
demonstrated that elevation of apoptotic DNA fragmentation was accompanied with 
mitochondrial cytochrome c, Smac, and AIF release, caspase-3 activation, and AIF nuclear 
translocation [103,127]. Collectively, these findings in C2C12 myotubes, along with findings 
in brain cells and cardiomyocytes, suggest that   H2O2 induces apoptosis by both caspase-
dependent and -independent mechanisms.  
 Ceramides have been shown to play a key role in apoptosis and have been implicated as 
an important second messenger that acts at the level of the mitochondria during TNF-α 
(extrinsic signaling) induced apoptosis. Treatments of cells and isolated mitochondria with the 
cell permeable ceramide analog, C2-ceramide, have been shown to inhibit electron transfer 
activity and increase ROS production [139].  C2-ceramide alters intracellular calcium 
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concentrations [140,141] and has been shown to activate the pro-apoptotic protein Bid [141] 
another protein that links the extrinsic and intrinsic pathways of apoptosis. C2-ceramide has 
also been shown to induce mitochondrial swelling [142], alter mitochondrial membrane 
potential [140], induce mitochondrial release cytochrome c and AIF [140,142], and activate 
caspases [141].  The results from the current study are in agreement with the literature as we 
found that C2-ceramide induces apoptosis in a dose-dependent manner.  We also found that C2-
ceramide increase caspase-3 and caspase-9 activity relative to control cells. In addition, 
western blot analysis revealed an increase in the pro-apoptotic protein Bax following exposure 
C2-ceramide.   
 
Induced Apoptosis Following Mitochondrial Biogenesis 
Although mitochondrial biogenesis did not affect basal apoptotic signaling, it was 
found that upregulating mitochondrial content significantly altered the apoptotic response 
following exposure to apoptotic stimuli. The most novel and exciting finding in the current 
study was that increased mitochondrial biogenesis in L6 myoblasts had a protective effect 
against staurosporine, H2O2, and C2-ceramide induced apoptosis. This is the first study to 
examine the specific effect of acute induction of mitochondrial biogenesis (through two 
different chemicals) on both basal apoptotic signaling and stress induced apoptotic signaling 
using three different apoptosis-inducing agents in a cell culture model. In addition, as 
mentioned previously we feel this is a more physiological model of mitochondrial biogenesis 
given the acute exposure and modest increase in mitochondrial biogenesis and content.  
The results of this study show that cells treated with SNAP or AICAR had a 
significantly higher healthy cell population and a significantly lower early and late apoptotic 
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cell population as determined by AnnexinV/PI staining following staurosporine exposure. 
Furthermore, caspase-3 and -9 activities were significantly reduced in SNAP- and AICAR-
treated cells compared to controls. Similar results were shown in the current study when L6 
myoblasts were exposed to C2-ceramide. The percentage of healthy cells was significantly 
higher and the percentage of early and late apoptotic cells was significantly lower in the 
biogenesis cells compared to control cells. Additionally, the percentage of apoptotic cells as 
determined by cell counting and by the cell cycle assay was significantly lower in both SNAP- 
and AICAR-treated cells. Furthermore, caspase-3 activity was significantly lower in both 
SNAP- and AICAR-treated cells while caspase-9 activity was only significantly lower in 
SNAP-treated cells. 
 Although to a lesser extent, it was also shown that mitochondrial biogenesis was 
protective against H2O2 induced apoptosis. The results show that there is a significantly higher 
proportion of healthy cells as well as a significantly lower proportion of early apoptotic cells in 
the SNAP- and AICAR-treated cells compared to controls cells. In addition, the cell 
counting/size analysis and cell cycle results show that the proportion of apoptotic cells was 
significantly lower in the mitochondrial biogenesis groups in comparison to the controls. 
Interestingly, caspase-3 and -9 activities were not found to be significantly different between 
groups following H2O2 exposure. Bianchi et al. [55] reported similar findings using L6 
myotubes. They found that L6 myotubes overexpressing PGC-1α had significantly increased 
mitochondrial content and were protected against calcium-mediated cell death induced by C2-
ceramide. Interestingly, they also showed that these cells were not protected against 
staurosporine induced apoptosis. However, Bianchi et al. used a dosage of 1μM staurosporine 
for 3 hours and their experiments were performed on differentiated L6 myotubes whereas the 
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current study used a dosage of 2μM staurosporine for 4 hours. In addition, Bianchi et al. used 
Hoechst staining to determine apoptotic cells, whereas the current study utilized AnnexinV-
FITC/PI, cell count/size analysis, cell cycle analysis, and caspase activation were to determine 
apoptotic cells.  The Hoechst staining technique utilized by Bianchi et al. relies on manual 
counting of apoptotic nuclei whereas the techniques used in the current study are much more 
sensitive.  Furthermore, the dosage of staurosporine used by Bianchi et al. may not have been 
enough to reveal differences between groups.  These differences in methodological approaches 
may contribute to the differences found in the current study regarding staurosporine-mediated 
cell death. 
With the few exceptions noted before, few differences were observed in the apoptotic 
protein expression between biogenesis cells and control cells. A notable exception was the 
change in Smac, Bcl-2, and ARC protein expression. Smac was found to be significantly 
higher in control cells compared to the mitochondrial biogenesis cells following exposure C2-
ceramide suggesting it may play a role in the increase in apoptotic cells seen in this population. 
Bcl-2 protein was significantly higher in the SNAP-treated group following exposure to H2O2. 
Bcl-2 seemed to be slightly elevated in the SNAP-treated cells across all apoptosis-inducing 
groups. NO has been reported to be related to increases in Bcl-2 content in the literature 
[145,146] and could explain these findings. Interestingly, ARC protein expression was found to 
be significantly lower in the SNAP-treated group following exposure to H2O2. It also showed a 
trend (p=0.07) towards being decreased in both biogenesis groups following exposure to 
staurosporine. These interesting results could possibly be explained by how ARC is regulated. 
It is possible that ARC becomes upregulated in response to cellular stress to prevent further 
damage and apoptosis. This type of adaptation has been shown to occur in the anti-apoptotic 
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protein XIAP in response to cellular stress [145].  If ARC regulation behaves in a manner 
similar to XIAP, then in this situation, it is possible that the biogenesis groups are less stressed 
following staurosporine administration and therefore ARC does not increase to the same 
degree as control cells. Further studies will need to be conducted to confirm these hypotheses. 
Furthermore, many apoptotic inducing agents have been shown to induce differentiation, as 
well as apoptosis [146,147]. In neuronal cell lines, differentiation has been shown to be 
associated with protection against apoptosis [148,149].  Moreover, the differentiation state of 
cells can also affect expression of certain proteins. Unpublished data from our lab has shown 
that ARC protein content becomes upregulated during differentiation. In the current study, it is 
possible the control cells, being more sensitive to the apoptotic agents, were also more inclined 
to begin differentiation. An increase in the number of cells undergoing differentiation could 
explain the higher ARC protein content seen in the control cells.  
Some interesting, yet confounding results were also found when western blot analysis 
was performed on antioxidant enzymes following exposure to apoptosis inducing agents. For 
example, CuZnSOD protein content was significantly lower in the SNAP-treated group 
following exposure to H2O2.  In contrast, catalase protein content was elevated in SNAP- and 
AICAR-treated cells following staurosporine exposure. It is likely that the increased catalase 
level is an artifact of the higher basal catalase levels observed in the SNAP- and AICAR-
treated cells.  The findings in the current do not follow the trend shown in the literature. For 
example, Shull et al. [150] have demonstrated that MnSOD mRNA expression is increased 2 
hours following oxidant exposure and reach a maximum expression at 24 hours. Furthermore, 
they showed that MnSOD protein content was elevated at 24 hours and 48 hours following 
oxidant exposure. Kahl et al. [151] also show significant increases in catalase and MnSOD 
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mRNA following exposure to H2O2. These findings suggest that antioxidant enzymes can be 
upregulated in response to cellular stress which is in contrast to the present findings. It is 
possible that the SNAP- and AICAR-treated cells were under less ―stress‖ and therefore, there 
was no induction of MnSOD and CuZnSOD; however, this remains to be determined.  
Some more confounding results were also found upon examining the intracellular ROS 
generation. Following staurosporine administration, DCF fluorescence was significantly higher 
in the AICAR-treated group and tended to be higher in the SNAP-treated group (p=0.075). 
These results could be explained by the binding characteristic of the fluorescent dye. Following 
oxidation by cellular reactive oxygen species, the resulting fluorescent product, DCF, is 
retained inside living cells due to electric charges and emits light with intensity proportional to 
the level of cellular oxidative stress [152].   Using hydroethidine (HE), a dye similar to DCF-
HA (it must be oxidized to fluoresce), Torres-Roca et al. [153] demonstrated that a population 
of late stage apoptotic cells was HE negative, indicating they were likely unable to oxidize HE 
due to lack of metabolism. Similarly, Wang et al. [154] reported that apoptotic cells had 
decreased production of reactive oxygen intermediates. Collectively, these findings indicate 
that DCF may not be able to be retained in apoptotic cells due to cellular membrane rupture 
and loss of electric charge. Our findings show that the percentage of healthy cells was 
significantly lower and the percentage of apoptotic cells was significantly higher in the control 
cells.  The presence of more apoptotic cells within this population would result in a lower mean 






Potential Mechanisms for Protection 
Some potential mechanisms for protection against apoptosis can be proposed from the 
results of the current study and by examination of the literature. One potential mechanism often 
cited in the literature is that increased antioxidant capacity can reduce damage from ROS and 
protect cells from apoptosis. A study by Pong et al. [155] found that the two synthetic 
superoxide dismutase/catalase mimetics (EUK-134 and EUK-189) were able to attenuate the 
apoptotic response in neuronal cells following staurosporine exposure. Similarly, 
overexpression models of catalase [156,157], MnSOD, and CuZnSOD [158] have shown to 
decrease cell susceptibility to apoptotic cell death. These studies indicate that the upregulation 
of MnSOD and catalase observed in the current study in response to SNAP and AICAR 
treatment could partially explain the decreased susceptibility of myoblasts to apoptosis.  
Another potential mechanism of protection could be through increased intracellular 
calcium buffering capacity. Mitochondria can act as a ‗calcium sink‘ to buffer intracellular 
concentrations by up-taking free calcium from the cytosol [55]. High intracellular calcium 
concentrations can lead to increased activation of pro-apoptotic factors such as calpains and 
Bax [22,23,24]. Interestingly, a direct link has been shown to exist between the endoplasmic 
reticulum (ER) and the mitochondria, where calcium release from the ER under stress 
conditions is immediately taken up by the mitochondria [159]. Although buffering calcium 
from the mitochondria is important, too much calcium intake into the mitochondria can cause 
swelling, pore formation, or bursting of the mitochondria leading to apoptosis through the 
release of pro-apoptotic proteins such as cytochrome c, Smac and AIF [160].  Staurosporine 
and C2-ceramide have been shown to cause large increases in intracellular calcium 
concentrations [123,140,141], therefore it is possible that the greatest protection against 
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apoptosis observed in this study to these agents may have been due to increased calcium 
buffering as a result of increased mitochondrial volume.  In a study performed by Bianchi et al. 
[55], it was reported following that in cells with increased mitochondrial content, individual 
mitochondria showed significantly lower mitochondrial calcium concentrations than the cells 
with lower mitochondrial content. The increased mitochondrial volume in these cells allows 
intramitochondrial calcium to distribute in a larger volume, resulting in reduced overall 
mitochondrial calcium concentration. Collectively, these results suggest increasing 
mitochondrial content allows for the increased removal of calcium from the cytosol while at 
the same time minimizing mitochondrial swelling thereby decreasing apoptotic activation by 
calcium. 
 
Summary and Conclusions 
 In summary, this is the first study to demonstrate that upregulation of mitochondrial 
content at physiological levels can protect L6 myoblast from apoptosis induced by multiple 
agents. The results of this study show that apoptotic signaling, measured by AnnexinV-
FITC/PI staining, cell cycle assays, caspase-3 and -9 activity, cell size/counting analysis, and 
antioxidant protein content indicate that upregulating mitochondrial is protective against 
staurosporine-, H2O2-, and C2-ceramide-induced apoptosis.  Mitochondrial ROS production 
was not significantly altered between groups while total cellular ROS production seemed to be 
slightly increased in the SNAP- and AICAR-treated groups. These results are in disagreement 
with the hypothesis but could be explained by the higher retention and oxidation of DCF in 
living cells. Overall, it was determined that increasing mitochondrial content in L6 myoblasts 
provides protection against stress induced apoptosis, and it is likely that this protection is 
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mediated by a combination of increased antioxidant capacity and mitochondrial calcium 
buffering capacity.  
 
Limitations 
 The current study was performed on L6 myoblasts. Myoblasts are undifferentiated 
muscle cells but are characteristically different from differentiated myotubes and terminally 
differentiated muscle in vivo. The goal of the experiment was to isolate the mitochondrial 
biogenesis effect to determine if increased mitochondrial content provided protection against 
apoptosis. As AICAR and SNAP have been used for numerous applications and have shown to 
induce several effects within cells, it is possible that other cellular responses (independent of 
mitochondrial biogenesis) could also be responsible for the protective effects observed. 
Nevertheless, we used two different agents to induce mitochondrial biogenesis and found 
similar results.   
 Additionally, this study utilized western blotting techniques to determine the 
mechanisms associated with the protecting the cells from apoptosis. However, the incubation 
times of the apoptosis inducing agents were either 4 hours (staurosporine) or 24 hours (H2O2 
and C2-ceramide) which may not have been long enough to observe changes in some proteins. 
Analysis of mRNA content could have been useful to obtain a more in depth understanding of 
the differences between control and biogenesis groups. Furthermore, western blots in the 
current study were performed on whole cell lysates. A better understanding of the molecular 
pathways regulating the apoptotic signaling could be gained by performing western blots on 
subcellular fractions.  
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 For DCF and MitoSOX analysis, the initial flow cytometry set-up was performed on 
healthy/viable L6 myoblast populations.  Upon completion of the experiments and upon 
analysis of the data, it was determined that the flow cytometer settings used  did not allow for 
discrimination of the viable cell population from the apoptotic cell population using forward or 
side scatter properties. Furthermore, a dual staining procedure examining propidium iodide and 
DCF fluorescence simultaneously would allow for easy discrimination of healthy cells from 
apoptotic cells while at the same time allowing for the examination of differences in DCF 
fluorescence in these two populations.  Adjustments of the instrument settings or use of the 
dual staining method may provide a more accurate representation of mitochondrial and total 
cellular ROS generation within the cells.  
 
Future Directions 
 Future cell culture studies should examine the mechanism by which these cells are 
protected. Further insight into the antioxidants and calcium buffering is needed to determine 
how the protective effect observed in these cells is mediated.  In addition, future studies should 
examine whether these protective effects are also seen in terminally differentiated myotubes. 
More specifically, it should be examined whether differentiated myotubes are more protected 
against H2O2 or C2-ceramide induced cell death. As differentiated myotubes are multinucleated 
and contain a much more developed sarcoplasmic reticulum than myoblasts, it is possible that 
differences in apoptotic susceptibility to different inducing agents may become evident. 
 Furthermore, future studies should evaluate these findings at the whole tissue level. 
Many studies have been published examining endurance training and its effect on basal 
apoptotic signaling in both healthy and disease states. Further research needs to be completed 
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to determine the individual protective mechanisms by which exercise and mitochondrial 
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Appendix A – Supplementary Data 
 
Figure A1. MitoTracker Green showing increased mitochondrial content in response to 
intermittent exposure to SNAP and AICAR.  Briefly, cells seeded on glass coverslips and 
were exposed to nothing (Control), 100μM SNAP or 2mM AICAR for 5hrs/day for 5 days.  
Cells were then washed with PBS. Fresh PBS was added to the dish and cells were stained with 
MitoTracker Green (400nM) and DAPI for 30 minutes in the dark at 37
o
C.   Cells were then 





Figure A2. AnnexinV-FITC/PI Staining Dose Response to Apoptotic Stimuli. Analysis of 
AnnexinV-FITC/PI staining following exposure to increasing concentrations of staurosporine 
(A), H2O2 (B), and C2-ceramide (C). 
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Figure A3. Apoptotic Stimuli Dose-Response Caspase-3 Activity. Pilot results showing that 
with increasing concentrations of staurosporine (A) and H2O2 (B), there is a step-wise increase 
in caspase-3 activity. 
 
 
Figure A4. Relative proportion of cells in the G0 phase.  To examine if cells were in 
different phase of cell cycle, the relative proportion of cells in the G0 phase was examined 
under basal conditions, or following treatment with staurosporine, H2O2, or C2-ceramide. There 







Appendix B – Pilot Study Data 
Mitochondrial Biogenesis: 
 To verify that induction of apoptosis is possible by treatment with the AMPK activator 
AICAR and the nitric oxide donor SNAP, western blots for AIF, cytochrome c, and PGC-1α 
were performed. The results show that intermittent administration of AICAR for 5 hours a day 
for results in an increase in AIF, cytochrome c, and PGC-1α in comparison to controls (Fig. 
A5). Since AIF and cytochrome c are both markers of mitochondrial content, and PGC-1α is a 




A           B 
 
Figure A5. Mitochondrial Biogenesis. Treatment of myoblasts with AICAR for 5 
hours per day for 5 days results in upregulation of AIF, SNAP, and PGC-1α in comparison to 
control cells (A). Treatment of myoblasts with SNAP for 5 hours per day for 5 days results in 
upregulation of AIF and PGC-1α in comparison to untreated control cells. 
 
 
Annexin/PI Flow Cytometry Assay: 
 To determine an appropriate concentration of staurosporine (STS) and hydrogen 
peroxide (H2O2) to use to induce apoptosis and verify that apoptotic cells could be identified 
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using this protocol, varying increasing levels of STS or H2O2 were administered to cells. For 
STS, final concentrations of 0µM, 0.5µM, 1.0µM, and 2.0µM were used while for H2O2 final 
concentration of 0mM, 0.5mM, 1.0mM, and 2mM were used. The attempt to separate apoptotic 
and necrotic population from healthy cells was successful using this assay technique (Fig. A6). 
The technique was further verified by the fact that increasing concentrations of STS or H2O2 




A       B 
 
 
Figure A6. Flow cytometry analysis of L6 myoblast treated with H2O2. (A) shows the 
original scatter plot of all myoblasts while  (B) illustrates the separation of apoptotic and 
necrotic cells from the healthy population. In both (A) and (B), healthy cells do not express any 
fluorescence and are represented by the red dots. Purple dots represent cells that express only 
AnnexinV-FITC fluorescence and are classified as early apoptotic. Late apoptotic cells are 







Caspase Activity Assay: 
In concurrence with the AnnexinV/PI flow cytometry assay, the effect of increasing 
concentrations of H2O2 and STS on caspase-3 activity was analyzed. Increasing dosages of 
H2O2 or STS resulted in an increase in caspase-3 activity in control cells (Fig. A7).  It was also 
shown 2 µM STS administration resulted in a slight decrease of caspase-3 in AICAR treated 
groups and a slight increase in caspase-3 activity in SNAP treated group. Induction of 
apoptosis with 2mM H2O2 resulted in decreased caspase-3 activity in groups administered 
AICAR and SNAP (Fig. A7). 
 
Figure A7. Casapse Activity. (A) and (C) demonstrate effect of increasing STS and H2O2 
concentration respectively on caspase-3 activity. (C) demonstrates effect of 5days SNAP and 
AICAR administration on STS induced activation of caspase-3. (D) demonstrates effect of 5 
days of SNAP and AICAR administration on H2O2 induced caspase-3 activation. 
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Cell Cycle Assay 
 
  The cell cycle assay allows for cells to be separated according to their phase in the cell 
cycle. The resultant peaks found in the flow cytometry analysis represent cells in the Go/G1, S, 
and G2/M phase. The assay also allows us to separate out apoptotic cells. To verify this 
procedure, control cells were treated with 2mM H2O2 to induce apoptosis and the subsequent 
results are shown in Fig. A8.   
 
 
Figure A8. Demonstrtion of propidium iodide (PI) cell cycle flow cytometry assay. Cells 
can be separated into four groups based on PI fluorescence in the FL2-area channel: apoptotic, 
Go/G1, S, and G2/M. Apoptotic cells express lower fluorescence in the FL2-Area compared to 
channel due to breakdown of nuclear material and DNA. 
